Today: 7 February 2026
Subscribe

AlphaTime Acquisition Corp (ATMC) Skyrockets After HCYC Merger Vote: Latest News, Deal Terms and 2026 Outlook

AlphaTime Acquisition Corp (ATMC) Skyrockets After HCYC Merger Vote: Latest News, Deal Terms and 2026 Outlook

AlphaTime Acquisition Corp (NASDAQ: ATMC) – a small SPAC that most investors ignored for two years – just turned into one of the wildest tickers on the screen. As of the morning of December 9, 2025, ATMC was flagged among the top pre‑market gainers, with shares changing hands around $104.70, up roughly 602% from the prior close. RTTNews+1 The move comes just days after shareholders approved a complex merger with Hong Kong insurance broker HCYC and after the Form F‑4 registration statement for the deal became effective. For anyone trying to understand what on earth is going on with this
9 December 2025
··
AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

Date: December 9, 2025 AeroVironment, Inc. (NASDAQ: AVAV), the U.S. defense-technology and drone specialist behind the Puma and Switchblade systems, heads into its fiscal Q2 2026 earnings report tonight with fresh contract wins, new software products, and a stock that is up sharply over the past year but still well below its 2025 peak. On December 9, 2025, AVAV trades around $282 per share, giving the company a market capitalization of roughly $14 billion. The stock is up about 80–85% over the last 12 months, yet remains more than 30% below its 52‑week high of $417.86, leaving investors debating whether
9 December 2025
··
Coca-Cola (KO) Stock on December 9, 2025: Price, Fresh News, Analyst Targets and Long‑Term Forecast

Coca-Cola (KO) Stock on December 9, 2025: Price, Fresh News, Analyst Targets and Long‑Term Forecast

As of December 9, 2025, The Coca-Cola Company (NYSE: KO) sits in its usual sweet spot: not a meme rocket ship, but a slow, dividend‑dripping machine that institutions, pension funds and Warren Buffett continue to hug tightly. Today’s backdrop is a mix of solid earnings momentum, active institutional repositioning, bullish Wall Street targets – and a new legal overhang from San Francisco’s lawsuit over ultra‑processed foods. Where Coca-Cola Stock Stands Today Coca-Cola shares most recently closed at about $70.25, up 0.36% on Monday, December 8, 2025. That puts the stock near the middle of its 52‑week range of roughly $60.62
9 December 2025
·
Berkshire Hathaway Stock (BRK.A, BRK.B) Today: Leadership Shake-Up, Q3 Earnings, and 2026 Forecasts – December 9, 2025

Berkshire Hathaway Stock (BRK.A, BRK.B) Today: Leadership Shake-Up, Q3 Earnings, and 2026 Forecasts – December 9, 2025

Berkshire Hathaway Inc. is entering one of the most important transitions in its history, and the stock is trading under a mix of excitement and unease. As of midday U.S. trading on 9 December 2025, Berkshire Hathaway Class B shares (BRK.B) change hands at around $497, down roughly 1–1.5% on the day. Class A shares (BRK.A) trade near $745,000, also modestly lower. At the same time, the conglomerate is: Here’s how all of that fits together for investors watching Berkshire Hathaway stock on 9 December 2025. 1. Berkshire Hathaway stock today: BRK.A and BRK.B snapshot Berkshire remains one of the
9 December 2025
····
Paranovus Entertainment (PAVS) Stock Rockets in Pre‑Market on CEO Report After 18,037% Revenue Surge – December 9, 2025 Update

Paranovus Entertainment (PAVS) Stock Rockets in Pre‑Market on CEO Report After 18,037% Revenue Surge – December 9, 2025 Update

NEW YORK – December 9, 2025 – Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS) is back on day‑trader radar after another bout of extreme volatility. According to Benzinga, Paranovus shares jumped as much as 54.8% to $1.02 in pre‑market trading on Tuesday after a report that the company had named Rich Wheeless as CEO.Benzinga That move comes just four days after Paranovus published interim results showing ~18,037% year‑over‑year revenue growth and a swing to a small profit for the six months ended September 30, 2025.PR Newswire By contrast, most data providers still show Monday’s regular‑session close at $0.0489, up 33.6% on
9 December 2025
·
Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall AG (XETRA: RHM, also traded as RHMG.DE and RNMBY in the U.S.) is back in the spotlight on December 9, 2025, as German defence stocks rally and Berlin prepares to sign off on some of the largest military procurement packages in its modern history. By early afternoon in Europe, Rheinmetall shares were trading around €1,640–1,645, up roughly 1–4% on the day, leaving the stock about 10% higher over the last five sessions and more than 160% higher year‑to‑date.MarketScreener+1 At the same time, analysts’ 12‑month price targets mostly cluster around €2,200–2,300, implying roughly 40–45% upside if those projections are met.MarketScreener+1
9 December 2025
··
Federal National Mortgage Association (Fannie Mae) Stock in December 2025: Michael Burry’s Big Bet, Trump’s IPO Plans and What Comes Next

Federal National Mortgage Association (Fannie Mae) Stock in December 2025: Michael Burry’s Big Bet, Trump’s IPO Plans and What Comes Next

Published December 9, 2025 – For informational purposes only, not investment advice. Where Fannie Mae’s Stock Stands Now Federal National Mortgage Association – better known as Fannie Mae and traded over-the-counter as FNMA – has turned from a forgotten bailout relic into one of 2025’s most closely watched speculative trades. As of the close on December 8, 2025, Fannie Mae’s common stock changed hands at about $11.44 per share, up roughly 8% over the past five trading days and nearly 250% year-to-date, according to MarketScreener’s summary of OTC trading. MarketScreener StockInvest, a technical-analysis service, records a similar last close of
9 December 2025
····
Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs (ALAB) Stock Jumps on AI Optimism: Latest News, Analyst Price Targets and Forecasts for December 9, 2025

Astera Labs, Inc. (NASDAQ: ALAB) is back in the spotlight on Tuesday, December 9, 2025, as the AI‑infrastructure specialist rallies and fresh analyst commentary and institutional filings reshape the narrative around one of the market’s most closely watched semiconductor IPOs. As of late-morning U.S. trading, Astera Labs shares were changing hands around $175.74, up roughly 9% on the day, after closing near $161 in the prior session. That move comes after several weeks of heavy volatility following its latest earnings report and the AWS re:Invent conference. Below is a comprehensive look at today’s news, recent corporate developments, Wall Street forecasts,
9 December 2025
·
Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

Toll Brothers Stock Slides After Q4 2025 Earnings Miss and Cautious 2026 Outlook: What It Means for TOL Investors

December 9, 2025 — New York Stock Exchange: TOL Toll Brothers, Inc. (NYSE: TOL), the largest U.S. builder of luxury homes, is under pressure today after reporting fiscal Q4 2025 results that combined a solid revenue performance with softer margins, weaker cash flow, and a cautious outlook for 2026. Shares are trading around $136 in early Tuesday action, down roughly 2% from Monday’s close of $138.94, as investors digest an earnings-per-share (EPS) miss and guidance that points to lower deliveries next fiscal year. Even after the pullback, the stock remains up around 8–10% year-to-date and not far from its 52‑week
9 December 2025
··
NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

Dateline: December 9, 2025 NextEra Energy, Inc. (NYSE: NEE) is back in the spotlight this week as investors digest a flurry of news: a landmark AI-focused partnership with Google Cloud, 2.5 GW of new clean‑energy contracts with Meta, an ambitious gas‑fueled data‑center strategy with Exxon, and updated long‑term earnings guidance out of its New York investor day. All of that is hitting the tape while the stock consolidates after a strong 2025 rally and a sharp pullback in the last session. NextEra Energy stock today: price, performance and dividend By late morning U.S. trading on December 9, 2025, NextEra Energy
9 December 2025
···
Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited (SE) Stock: Q3 2025 Earnings, $1 Billion Buyback and 2026 Price Targets Explained

Sea Limited’s stock has had a whiplash year. After soaring earlier in 2025, the shares have pulled back sharply following third‑quarter earnings, even as the company delivered some of its strongest growth metrics in years and announced a $1 billion share repurchase program. As of intraday trading on December 9, 2025, Sea Limited (NYSE: SE) is changing hands around $128 per share, down about 4% on the day and roughly a third below its 52‑week high near $199.dcfmodeling.com The question now dominating investor conversations: is this a buying opportunity, or a warning sign that expectations have run too far ahead
9 December 2025
··
Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading like a Hollywood cliffhanger on Tuesday, December 9, 2025. Shares are changing hands around the mid‑$27 range after jumping more than 4% intraday, extending a rally that has seen the stock climb roughly 140–150% over the past year. Smartkarma The catalyst: Paramount Skydance’s surprise all‑cash hostile bid of $30 per share, valuing Warner Bros. Discovery at about $108.4 billion including debt and directly challenging Netflix’s already‑signed $72 billion cash‑and‑stock agreement for WBD’s studios and streaming operations. Reuters+2PR Newswire+2 Below is a detailed look at the latest news, the takeover mechanics, analyst forecasts,
9 December 2025
·
Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune, Inc. (NASDAQ: ALT) has become a tightly wound biotech story heading into year‑end 2025. The small‑cap developer of liver and metabolic drugs is changing its CEO just weeks before a pivotal 48‑week readout in its lead MASH trial, while Wall Street models still point to triple‑digit upside from today’s share price. As of mid‑day on December 9, 2025, Altimmune stock trades around $5.61 per share, implying a market capitalization of roughly $550 million. Stock Titan That price sits well above its autumn lows but far below analyst targets that cluster in the mid‑teens to high teens. Below is a
9 December 2025
·
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

As Cemtrex, Inc. (NASDAQ: CETX) heads into trading on Tuesday, December 9, 2025, the tiny tech stock is coming off one of the wildest sessions on the Nasdaq. On Monday, December 8, Cemtrex shares closed at $7.05, up 129.64% from Friday’s close of $3.07, after trading in an extraordinary intraday range of $4.84 to $9.70. StockAnalysis+2StockInvest+2Pre‑market quotes early Tuesday show the stock giving back part of that move, trading around the low‑$6 area (roughly –14% versus Monday’s close), but still far above last week’s levels. StockAnalysis+1 Despite the eye‑popping rally, Cemtrex remains a micro‑cap: its market value sits around $5
9 December 2025
··
Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Data and news current as of 9 December 2025. This article is for informational purposes only and is not financial advice. Sezzle stock in December 2025: from hyper-growth to “serious contender” Sezzle Inc (NASDAQ: SEZL), the buy-now-pay-later (BNPL) fintech once written off as a niche player, has turned into one of 2025’s wildest rides on the Nasdaq. After a run that saw the stock up around 1,000% over the past year at one point, followed by drawdowns of 40%–70% from its peak, Sezzle has settled—for now—into the role of highly volatile, profitable growth stock with real earnings and real scrutiny.
9 December 2025
··
‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

Published: 9 December 2025 A heavily mutated flu strain — A/H3N2 subclade K, often dubbed the “K-strain” or “superflu” — is now dominating the 2025–26 flu season and driving record levels of illness in parts of the UK and beyond. On Tuesday, new analysis showed that this K-strain now accounts for around 90% of flu samples in the UK and Japanand has been detected on every continent.The Independent+1 At the same time, NHS leaders in London warn of the “biggest flu wave ever” in the capital, with hospital flu admissions tripling compared with this time last year and “no peak yet in sight”.The Standard Yet there is some good news: early
9 December 2025
UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

The UK stock market spent Tuesday 9 December 2025 in a holding pattern, with the FTSE 100 drifting around 9,650 points and ending effectively flat, as traders waited for a key US Federal Reserve decision and next week’s Bank of England meeting. Reuters Beneath the calm index level, trading activity was intense in a familiar set of big‑name stocks: banks, energy giants, consumer staples, telecoms and tobacco. According to the London Stock Exchange and live dealing platforms, volume was concentrated in Lloyds, Legal & General, Glencore, Vodafone, Barclays, Tesco, BP, BT, Rolls‑Royce, Magnum Ice Cream and British American Tobacco, among others. Hargreaves Lansdown This article
9 December 2025
··
UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

The UK stock market spent Tuesday, 9 December 2025, in a cautious mood, with a handful of big names doing most of the damage. The FTSE 100 slipped around 0.1% to roughly 9,640, its lowest close in about two weeks, as investors positioned for a crucial Federal Reserve decision and another Bank of England rate call. TradingView+1 While the index is still hovering near record highs for 2025, British American Tobacco, Chemring and Ashtead were among the standout losers today, and Monday’s sharp falls in Unilever, Barratt Redrow, JD Sports Fashion, Persimmon and Entain are still shaping sentiment. TechStock²+1 Market snapshot: Cautious FTSE 100, weak consumers Two
9 December 2025
··
UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

The UK stock market nudged higher on Tuesday 9 December 2025, but beneath the calm headline numbers there were some dramatic individual moves – led by a double‑digit jump in Unilever and sharp gains in WPP, defence contractor Babcock, and mid‑cap names such as Trustpilot, Ocado, Helios Towers, Man Group and Moonpig. The FTSE 100 closed fractionally up at 9,653.19 (+0.08%), while the FTSE 250 added 0.17% to 21,957.79, both indices finishing in positive territory after a cautious session. European markets more broadly were also slightly higher, with investors focused on the US Federal Reserve’s two‑day policy meeting that begins later today.
9 December 2025
·
Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Snapshot: Where Structure Therapeutics Stock Stands Today Structure Therapeutics Inc. (NASDAQ: GPCR) has suddenly moved from niche obesity biotech to front‑page market story. As of December 9, 2025, GPCR is trading around $69.98, up roughly 102% in a single session compared with its previous close near $34.56. The stock’s intraday range on December 8 ran from $44.74 to $94.90, marking a new 52‑week high, and lifting its market capitalization to about $4.25 billion.StockAnalysis+1 This explosive move followed positive Phase 2b trial data for the company’s oral GLP‑1 obesity drug aleniglipron and the announcement of a proposed $500 million public offering
9 December 2025
··
1 … 1,033 1,034 1,035 1,036 1,037 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop